xml version="1.0" encoding="UTF-8"?


C\_2019036EN.01003701.xml


| | | | |
| --- | --- | --- | --- |
| 29.1.2019 | EN | Official Journal of the European Union | C 36/37 |

---

Prior notification of a concentration

(Case M.9243 — KKR/China Resources/Genesis Care)

Candidate case for simplified procedure

(Text with EEA relevance)

(2019/C 36/11)

1.

On 22 January 2019, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 [(1)](#ntr1-C_2019036EN.01003701-E0001).

This notification concerns the following undertakings:

| | |
| --- | --- |
| — | KKR & Co. Inc. (‘KKR’, United States of America), |

| | |
| --- | --- |
| — | China Resources (Holdings) Company Limited (‘China Resources’, Hong Kong). |

KKR and China Resources acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of Genesis Care Pty Limited (‘Genesis Care’, Australia), China Resources’ subsidiary active in the provision of cancer care (primarily oncology) services in the United Kingdom, Spain and Australia, radiation therapy treatments for benign diseases in Spain and Australia, and cardiology, sleep and respiratory treatment services in Australia.

The concentration is accomplished by way of purchase of shares.

2.

The business activities of the undertakings concerned are:

—   for KKR: global investment firm which offers a broad range of alternative asset management services to public and private market investors and provides capital markets solutions for the firm, its portfolio companies and clients,

—   for China Resources: diversified holding company ultimately supervised by the State-owned Assets Supervision and Administration Commission of the State Council of the People’s Republic of China, which serves as the top level holding company for a group of companies operating a wide variety of businesses, such as consumer products (including retail, beer, food and beverages), power, real estate, cement, gas and pharmaceuticals, as well as various other businesses.

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 [(2)](#ntr2-C_2019036EN.01003701-E0002) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.9243 — KKR/China Resources/Genesis Care

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

| |
| --- |
| Email: COMP-MERGER-REGISTRY@ec.europa.eu |
| Fax +32 22964301 |
| Postal address: |
| European Commission |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

---

[(1)](#ntc1-C_2019036EN.01003701-E0001)  
[OJ L 24, 29.1.2004, p. 1](http://publications.europa.eu/resource/oj/JOL_2004_024_R_TOC) (the ‘Merger Regulation’).

[(2)](#ntc2-C_2019036EN.01003701-E0002)  
[OJ C 366, 14.12.2013, p. 5](http://publications.europa.eu/resource/oj/JOC_2013_366_R_TOC).

---